Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)

Conditions

Liver

Phase II-III

What is the purpose of this trial?

This partially randomized phase II/III trial studies how well cisplatin and combination chemotherapy works in treating children and young adults with hepatoblastoma or liver cancer after surgery. Drugs used in chemotherapy, such as cisplatin, doxorubicin, fluorouracil, vincristine sulfate, carboplatin, etoposide, irinotecan, sorafenib, gemcitabine and oxaliplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving combination chemotherapy after surgery may kill more tumor cells.

  • Trial with
    Children's Oncology Group (The)
  • Start Date
    05/23/2019
  • End Date
    03/30/2025

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8348

Trial Image

For more information about this study, contact:

Sharon Huie

  • Last Updated
    05/28/2019
  • Study HIC
    #2000024256